Biotech

Page 6 of 19

Will COVID-19 change how Big Pharma does clinical trials?
Magazine

Will COVID-19 change how Big Pharma does clinical trials?

By
May 15, 2020
Gilead-Sciences-Remdesivir
Health

Remdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?

By
May 1, 2020
George Scangos coronavirus czar biotech
Newsletters

Pharma vet and former Biogen chief to lead biotech industry’s coronavirus response

By
March 2, 2020
What Andreessen’s ‘Bio Fund III’ means for healthcare
Newsletters

What Andreessen’s ‘Bio Fund III’ means for healthcare

By
February 5, 2020
For what ails Super Bowl athletes? Former NFL player talks up a new long-lasting knee treatment
Health

For what ails Super Bowl athletes? Former NFL player talks up a new long-lasting knee treatment

By
February 2, 2020
Healthcare Predictions 2020
Commentary

Health Care Investors Predict 10 Ways the Industry Will Change in 2020

By Bob Kocher and Bryan Roberts
December 6, 2019
BeiGene FDA Approval Cancer
Newsletters

Chinese Biotech BeiGene Makes a Splash in Cancer Treatment With FDA Drug Approval

By
November 14, 2019
Amgen BeiGene China Bitoech
Newsletters

U.S. Biotech Amgen Strikes Major Deal to Expand China Presence

By
October 31, 2019
China Biotech Brad Loncar
Newsletters

How China Is Transforming the Biotech Industry: Brainstorm Health

By
October 8, 2019
VEN1019.Mir Imran-Rani Therapeutics-01
Magazine

How this 20-time founder with hundreds of patents got his start

By
October 1, 2019
Biotech bad day
Health

About Biopharma’s Ridiculously Bad Day: Brainstorm Health

By
August 9, 2019
Reshma Kewalramani CEO Vertex
Commentary

A $43 Billion Biotech Now Has a Female CEO: Brainstorm Health

By
July 25, 2019
Moderna IPO biotech
Health

Moderna Had the Biggest Biotech IPO Ever. Here’s What That Says About the Industry’s Future

By
December 8, 2018
Moderna IPO MRNA
Health

Controversial Startup Moderna Just Filed for the Biggest Biotech IPO Ever

By
November 9, 2018
Biotech IPO Allogene
Health

Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO

By
October 11, 2018

Most Popular